GERAADA评分对急性A型主动脉夹层30天死亡预测的外部验证
本研究回顾性纳入2010至2020年单中心连续371例急性A型主动脉夹层手术患者,评估GERAADA评分对30天死亡预测的准确性。结果显示全体队列实际与预测30天死亡率分别为15.1%与15.7%(P=0.776),26个亚组预测均准确。术前复苏、高龄及其他/未知灌注不良为独立危险因素。
要点
- GERAADA评分对全体队列及26个亚组30天死亡预测准确。
- 实际vs预测30天死亡率:15.1% vs 15.7%(P=0.776)。
- 术前复苏、高龄、其他/未知灌注不良为独立危险因素。
核心结论
- GERAADA评分对急性A型主动脉夹层术后30天死亡预测准确,基于网络平台易于获取,仅需基本术前临床参数。
研究设计与样本
- 回顾性单中心研究,纳入2010至2020年连续371例急性A型主动脉夹层手术患者,收集11项术前参数,由不知情的心脏外科医生通过网页应用个体化计算GERAADA评分。
主要发现
- 全体队列实际与预测30天死亡率分别为15.1%与15.7%(P=0.776),26个亚组预测均准确。
- 术前复苏(P<0.001)、高龄(P=0.042)及其他/未知灌注不良(P=0.032)为独立危险因素。
- 平均年龄62.7±13.5岁,男性233例(63%)。
临床怎么用
- GERAADA评分可通过网页平台用基本术前参数计算,有助于急诊决策,但需前瞻性临床试验进一步评估。
局限性
- 回顾性单中心设计,样本来自作者机构,结论需前瞻性临床 trial 进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The German Registry of Acute Aortic Dissection Type A (GERAADA) score to predict 30-day mortality in patients suffering from acute aortic dissection type A (AADA) was recently introduced. The aim of this study was to evaluate if the GERAADA score's prediction corresponds with the authors' institutional results. METHODS: All consecutive AADA patients between 2010 and 2020 were included. Retrospective data collection comprised 11 preoperative parameters: age, sex, previous cardiac surgery, inotropic support at referral, resuscitation before surgery, aortic regurgitation, preoperative hemiparesis, intubation/ventilation at referral, preoperative organ malperfusion, extension of aortic dissection and location of primary entry site. Calculations of the GERAADA score were individually performed by a cardiac surgeon blinded to the study for all patients via a web-based application (https://www.dgthg.de/de/GERAADA_Score). RESULTS: A total of 371 AADA patients were operated at the authors' institution. The mean age was 62.7 ± 13.5 years and 233 (63%) were males. Prediction of 30-day mortality was accurate for the entire study cohort (actual vs predicted 30-day mortality: 15.1% vs 15.7%; P = 0.776) as well as for all 26 subgroups. In addition, preoperative resuscitation (P < 0.001), advanced age (P = 0.042) and other/unknown malperfusion (P = 0.032) were identified as independent risk factors. CONCLUSIONS: The GERAADA score prediction of 30-day mortality after surgery is accurate, easily accessible due to its web-based platform and can be calculated with very basic preoperative clinical parameters. A prospective clinical trial is required to further evaluate the new GERAADA score as a useful tool to allow for improved decision-making in the emergency setting of AADA.
引用
- Luehr M, Merkle-Storms J, Gerfer S, et al. Evaluation of the GERAADA score for prediction of 30-day mortality in patients with acute type A aortic dissection. Eur J Cardiothorac Surg. 2021. PMID: 33374014. doi:10.1093/ejcts/ezaa455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。